Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial

Eur Respir J. 2017 Oct 5;50(4):1701183. doi: 10.1183/13993003.01183-2017. Print 2017 Oct.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / diagnosis
  • Coronary Artery Disease* / therapy
  • Diagnostic Errors / prevention & control
  • Endothelium, Vascular / physiopathology
  • Female
  • Humans
  • Long Term Adverse Effects / diagnosis
  • Long Term Adverse Effects / etiology
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Outcome Assessment, Health Care
  • Peak Expiratory Flow Rate*
  • Percutaneous Coronary Intervention / methods
  • Platelet Activation*
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Function Tests
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive / complications
  • Pulmonary Disease, Chronic Obstructive / diagnosis*
  • Risk Assessment / methods
  • Surveys and Questionnaires
  • Ticagrelor / administration & dosage*

Substances

  • Platelet Aggregation Inhibitors
  • Ticagrelor

Associated data

  • ClinicalTrials.gov/NCT02324660